Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124929503 | 12492950 | 3 | F | 20160531 | 20160728 | 20160623 | 20160804 | PER | US-ACTELION-A-US2016-137561 | ACTELION | 45.00 | YR | A | F | Y | 0.00000 | 20160804 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124929503 | 12492950 | 1 | PS | UPTRAVI | SELEXIPAG | 1 | Oral | 800 MCG, QD | 207947 | 800 | UG | TABLET | QD | ||||||
| 124929503 | 12492950 | 2 | SS | UPTRAVI | SELEXIPAG | 1 | Oral | 200 MCG, QD | 207947 | 200 | UG | TABLET | QD | ||||||
| 124929503 | 12492950 | 3 | SS | UPTRAVI | SELEXIPAG | 1 | Oral | 1400 MCG, BID | 207947 | 1400 | UG | TABLET | BID | ||||||
| 124929503 | 12492950 | 4 | SS | UPTRAVI | SELEXIPAG | 1 | Oral | 1600 MCG, BID | 207947 | 1600 | UG | TABLET | BID | ||||||
| 124929503 | 12492950 | 5 | SS | AMBRISENTAN | AMBRISENTAN | 1 | Unknown | 10 MG, QD | 1204767A, 1504768A | 0 | 10 | MG | QD | ||||||
| 124929503 | 12492950 | 6 | SS | ADCIRCA | TADALAFIL | 1 | Unknown | UNK | 0 | ||||||||||
| 124929503 | 12492950 | 7 | C | FIORICET | ACETAMINOPHENBUTALBITALCAFFEINE | 1 | U | 0 | |||||||||||
| 124929503 | 12492950 | 8 | C | TRAMADOL. | TRAMADOL | 1 | U | 0 | |||||||||||
| 124929503 | 12492950 | 9 | C | XARELTO | RIVAROXABAN | 1 | U | 0 | |||||||||||
| 124929503 | 12492950 | 10 | C | CETIRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 124929503 | 12492950 | 11 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124929503 | 12492950 | 1 | Pulmonary hypertension |
| 124929503 | 12492950 | 5 | Pulmonary hypertension |
| 124929503 | 12492950 | 6 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124929503 | 12492950 | Diarrhoea | |
| 124929503 | 12492950 | Dizziness | |
| 124929503 | 12492950 | Headache | |
| 124929503 | 12492950 | Nasal congestion | |
| 124929503 | 12492950 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124929503 | 12492950 | 5 | 20120712 | 0 |